ARCHIVES

Approval Granted For New Formulation of Lupron Depot

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Issues Statement On Endostatin Research

October 1, 1999

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001